VMCS

InnovaQor, Inc. confirms trading symbol change to INQR

Retrieved on: 
Monday, February 13, 2023
PALM, VMCS, OTC Markets Group, OTC, History, FINRA, Security (finance)

WEST PALM BEACH, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), confirms a new trading symbol, INQR, for its common shares will be effective on February 14, 2023

Key Points: 
  • WEST PALM BEACH, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), confirms a new trading symbol, INQR, for its common shares will be effective on February 14, 2023
    InnovaQor is pleased to confirm that FINRA has today confirmed the name change from VisualMED Clinical Solutions Corporation to InnovaQor, Inc., and the change of its trading symbol for its common stock from VMCS to INQR on OTC Markets, will be effective on February 14, 2023.
  • The Companys’ common shares will trade under the symbol INQR on OTC Markets at the open of markets on February 14, 2023.
  • There is no change to the cusip number representing the Companys’ common shares.
  • “We are pleased to have these final transition changes completed” said Sharon Hollis, CEO of InnovaQor, Inc. “We can now focus on creating a strong brand and trading history, for our new business and strategy”
    For further information on InnovaQor, Inc., please visit www.innovaqor.com

InnovaQor Provides a Summary of its Business and Plans

Retrieved on: 
Monday, November 28, 2022
Marketing, OTC, EHR, Communication, VMCS, Social media, Interview, PALM, Electronic health record, Security (finance), Happiness, Acquisition, Video game, Online shopping

Hollis explained that InnovaQor is a software development and implementation company specific to the healthcare sector.

Key Points: 
  • Hollis explained that InnovaQor is a software development and implementation company specific to the healthcare sector.
  • She explained that the purpose of the Company was to enhance business practices for providers and facilities, complimented with the provision of IT managed services to protect assets and patient data.
  • Jolly then asked Hollis to provide more information on the new communication product that had been mentioned in public disclosures.
  • The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

RENNOVA HEALTH, INC. PROVIDES Q3 2022 PERFORMANCE UPDATE

Retrieved on: 
Thursday, October 20, 2022
VMCS, U.S. Securities and Exchange Commission, Sale, PALM, Jamestown Hospital, Security (finance), Lagan, Private Securities Litigation Reform Act, Company, Intention, Interview, OTC, GLOBE, Risk, Risk management

WEST PALM BEACH, Fla., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on Q3 2022 performance, and other activities.

Key Points: 
  • WEST PALM BEACH, Fla., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on Q3 2022 performance, and other activities.
  • Jolly began the interview by referring to the previous quarterly reports and asked if the Company expected a positive report for the third quarter.
  • Jolly asked if there was any further progress from the previous press release on the proposed behavioral health services initiative.
  • Jolly then asked for an update on InnovaQor, Inc. and the plans after the sale of the Companys software division to InnovaQor.

InnovaQor Announces that its Form 10-12G is now Effective

Retrieved on: 
Wednesday, September 28, 2022
VMCS, PALM, Company, 8-K, U.S. Securities and Exchange Commission, OTC, CEO, Solution, Private Securities Litigation Reform Act, Security (finance), GLOBE, SEC, Communication

InnovaQor will begin filing annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, periodic reports on Form 8-K, and subject itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.

Key Points: 
  • InnovaQor will begin filing annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, periodic reports on Form 8-K, and subject itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.
  • This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
  • Actual results may differ from expectations and,consequently, you should not rely on these forward-looking statements as predictions of future events.
  • The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

InnovaQor Announces Successful Onboarding of New Montana Client for EHR Subsidiary

Retrieved on: 
Monday, September 19, 2022
VMCS, Electronic health record, Sale, PALM, Company, U.S. Securities and Exchange Commission, OTC, Solution, Private Securities Litigation Reform Act, Security (finance), GLOBE, Communication, Medicine, EHR, Online shopping, Risk management

WEST PALM BEACH, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), today announced the successful onboarding of a new multi-location facility to its Medical Mime EHR (Electronic Health Records) solution.

Key Points: 
  • WEST PALM BEACH, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (OTC: VMCS), today announced the successful onboarding of a new multi-location facility to its Medical Mime EHR (Electronic Health Records) solution.
  • InnovaQor is pleased to confirm that its subsidiary Medical Mime, Inc. has onboarded a new Montana-based behavioral health client whose three locations will transition from an existing EHR to its Medical Mime solution over a three-month period.
  • All Medical Mime clients pay an implementation fee to facilitate the installation of our EHR and training of staff, and then pay a monthly subscription fee based on the number of users.
  • Actual results may differ from expectations and,consequently, you should not rely on these forward-looking statements as predictions of future events.

InnovaQor Announces That Its Form 10-12G Registration Statement will become effective on September 27, 2022.

Retrieved on: 
Wednesday, September 14, 2022
VMCS, PALM, Company, 8-K, U.S. Securities and Exchange Commission, OTC, CEO, Solution, Private Securities Litigation Reform Act, Security (finance), GLOBE, SEC, Communication

The company will begin filing annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K, and subject itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.

Key Points: 
  • The company will begin filing annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K, and subject itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.
  • This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
  • Actual results may differ from expectations and,consequently, you should not rely on these forward-looking statements as predictions of future events.
  • The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.